Associations between Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio and Mortality in Patients with Ischemic Stroke Complicated by Pulmonary Infection: Based on the MIMIC-IV Database

YU Pei, XIA Wei, FU Ting, TANG Jialong

Journal of Hunan Normal University(Medical Science) ›› 2026, Vol. 23 ›› Issue (3) : 80-85.

PDF(3317 KB)
PDF(3317 KB)
Journal of Hunan Normal University(Medical Science) ›› 2026, Vol. 23 ›› Issue (3) : 80-85.
Clinical Medicine

Associations between Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio and Mortality in Patients with Ischemic Stroke Complicated by Pulmonary Infection: Based on the MIMIC-IV Database

  • YU Pei1, XIA Wei2, FU Ting1, TANG Jialong3
Author information +
History +

Abstract

Objective To investigate the relationship between NLR, PLR and post-hospital mortality in ischemic stroke patients with pulmonary infection, aiming to provide a basis for clinical treatment strategies. Methods We retrospectively collected data from the MIMIC-Ⅳ 3.0 database of patients with ischemic stroke complicated by pulmonary infection who met the study criteria. Using a tertile method, NLR and PLR were each divided into three groups. NLR and PLR were assessed in relation to patient survival and mortality risk using Kaplan-Meier (K-M) survival curves and Cox risk models. Subgroup analyses were also performed to explore differences between different subgroups. Results A total of 2249 patients with ischemic stroke complicated by pulmonary infection were included. K-M survival curves indicated that patients with NLR of 4.49~39.10 and PLR>810.12 had lower post-hospital mortality rates. Cox model showed that patients with an NLR>39.10 and a PLR between 0.54~138.85 had an increased risk of post-hospital mortality. Subgroup analysis revealed a significant association between NLR and post-hospital mortality in patients with ischemic stroke complicated by pulmonary infection and malignant tumors, and between PLR and post-hospital mortality in patients with ischemic stroke complicated by pulmonary infection and malignant tumors or metastatic solid tumors. Conclusion Combined assessment of the NLR and PLR has a certain predictive value for the risk of mortality in patients with ischemic stroke with pulmonary infection, providing a reference for the diagnosis and treatment of this disease.

Key words

MIMIC-Ⅳ / ischemic stroke complicated by pulmonary infection / mortality / neutrophil/lymphocyte ratio / platelet/lymphocyte ratio

Cite this article

Download Citations
YU Pei, XIA Wei, FU Ting, TANG Jialong. Associations between Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio and Mortality in Patients with Ischemic Stroke Complicated by Pulmonary Infection: Based on the MIMIC-IV Database[J]. Journal of Hunan Normal University(Medical Science). 2026, 23(3): 80-85

References

[1] CAI W, HU M, LI C, et al.FOXP3+ macrophage represses acute ischemic stroke-induced neural inflammation[J]. Autophagy, 2023, 19(4): 1144-1163.
[2] BOURNE JH, SUTHYA AR, WANROOY BJ, et al.Microglia are prominent producers of inflammatory cytokines during the hyperacute phase of ischemic stroke[J]. Commun Biol, 2025, 8(1): 1193.
[3] ENGELMANN B, MASSBERG S.Thrombosis as an intravascular effector of innate immunity[J]. Nat Rev Immunol, 2013, 13(1): 34-45.
[4] ANITUA E, PRADO R, PADILLA S.Evolutionary insight into immunothrombosis as a healing mechanism[J]. Int J Mol Sci, 2022, 23(15): 8346.
[5] WANG RH, WEN WX, JIANG ZP, et al.The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage[J]. Front Immunol, 2023, 14: 1115031.
[6] JOHNSON AEW, BULGARELLI L, SHEN L, et al.MIMIC-IV, a freely accessible electronic health record dataset[J]. Sci Data, 2023, 10(1): 1.
[7] GOLDBERGER AL, AMARAL LA, GLASS L, et al.PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals[J]. Circulation, 2000, 101(23): E215-E220.
[8] FEIGIN VL, BRAININ M, NORRVING B, et al.World Stroke Organization: global stroke fact sheet 2025[J]. Int J Stroke, 2025, 20(2): 132-144.
[9] BONKHOFF AK, KARCH A, WEBER R, et al.Female stroke: sex differences in acute treatment and early outcomes of acute ischemic stroke[J]. Stroke, 2021, 52(2): 406-415.
[10] DEHLENDORFF C, ANDERSEN KK, OLSEN TS.Sex disparities in stroke: women have more severe strokes but better survival than men[J]. J Am Heart Assoc, 2015, 4(7): e001967.
[11] WEBER R, KROGIAS C, EYDING J, et al.Age and sex differences in ischemic stroke treatment in a nationwide analysis of 1.11 million hospitalized cases[J]. Stroke, 2019, 50(12): 3494-3502.
[12] AKYEA RK, VINOGRADOVA Y, QURESHI N, et al.Sex, age, and socioeconomic differences in nonfatal stroke incidence and subsequent major adverse outcomes[J]. Stroke, 2021, 52(2): 396-405.
[13] WANG M, WANG CJ, GU HQ, et al.Sex differences in short-term and long-term outcomes among patients with acute ischemic stroke in China[J]. Stroke, 2022, 53(7): 2268-2275.
[14] ANRATHER J, IADECOLA C.Inflammation and stroke: an overview[J]. Neurotherapeutics, 2016, 13(4): 661-670.
[15] THOMAS MR, STOREY RF.The role of platelets in inflammation[J]. Thromb Haemost, 2015, 114(3): 449-458.
[16] FURLAN J, VERGOUWEN M, SILVER F.White blood cell count as a marker of stroke severity and clinical outcomes after acute ischemic stroke[J]. Neurology, 78(Meeting Abstracts 1): P03.011-P03.011.
[17] KIM J, SONG TJ, PARK JH, et al.Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction[J]. Atherosclerosis, 2012, 222(2): 464-467.
[18] KOUPENOVA M, CLANCY L, CORKREY HA, et al.Circulating platelets as mediators of immunity, inflammation, and thrombosis[J]. Circ Res, 2018, 122(2): 337-358.
[19] YE F, GARTON HJL, HUA Y, et al.The role of thrombin in brain injury after hemorrhagic and ischemic stroke[J]. Transl Stroke Res, 2021, 12(3): 496-511.
[20] YANG M, PAN Y, LI Z, et al.Platelet count predicts adverse clinical outcomes after ischemic stroke or TIA: subgroup analysis of CNSR Ⅱ[J]. Front Neurol, 2019, 10: 370.
[21] GHODSI H, ABOUEIMEHRIZI MA, KHOSHDEL AR, et al.Evaluation of combining Alberta stroke program early CT score (ASPECTS) with mean platelet volume, plateletcrit, and platelet count in predicting short- and long-term prognosis of patients with acute ischemic stroke[J]. Clin Neurol Neurosurg, 2021, 208: 106830.
PDF(3317 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉